Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials.

AIMS Despite its high clinical relevance, few studies have investigated depression in patients with atrial fibrillation (AF). We aimed to assess whether depressed mood was more common in persistent or paroxysmal AF patients in controlled models and report frequencies of major depressive disorder. METHODS AND RESULTS Cross-sectional data from two contemporary clinical trials were used to compare paroxysmal (n = 310) and persistent (n = 392) AF patients' depressed mood severity (measured by the Major Depression Inventory) with each trial including only one patient type. A four-category outcome of depressed mood severity was chosen as exposure variable. Ordinal logistic regression was applied to analyse the association of AF type with depressed mood in a crude model and a confounder control model. In the study sample, 8.4% were classified as having major depressive disorder [10.5% of persistent and 5.8% of paroxysmal patients; odds ratio (OR) = 1.89; 95% confidence interval (CI): 1.07-3.37], according to the diagnostic and statistical manual of mental disorders [(diagnostic and statistical manual of mental disorders (DSM-IV)] criteria. In both the age and sex adjusted crude model and in the confounder control model, the association of persistent AF with more severe depressed mood was significant (OR confounder controlled model = 1.44; 95% CI: 1.13-1.75, P = 0.007). CONCLUSION Persistent AF patients may suffer from more severe depressed mood than paroxysmal AF patients with similar symptom burden after controlling for relevant factors.

[1]  P. Kirchhof,et al.  [Patients suffering from atrial fibrillation in Germany. Characteristics, resource consumption and costs]. , 2012, Herz.

[2]  G. Breithardt,et al.  Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial , 2012, The Lancet.

[3]  S. Sears,et al.  Psychopathology and Symptoms of Atrial Fibrillation: Implications for Therapy , 2012, Journal of cardiovascular electrophysiology.

[4]  H. Crijns,et al.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  T. Reinhold,et al.  Patienten mit Vorhofflimmern in Deutschland , 2012, Herz.

[6]  T. Fetsch,et al.  Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial , 2012, Circulation. Arrhythmia and electrophysiology.

[7]  Pamela J. McCabe What patients want and need to know about atrial fibrillation , 2011, Journal of multidisciplinary healthcare.

[8]  W. Hacke,et al.  Paroxysmal Atrial Fibrillation Is More Prevalent than Persistent Atrial Fibrillation in Acute Stroke and Transient Ischemic Attack Patients , 2011, Cerebrovascular Diseases.

[9]  S. Riedel-Heller,et al.  Age- and gender-specific prevalence and risk factors for depressive symptoms in the elderly: a population-based study , 2011, International Psychogeriatrics.

[10]  A. Tveit,et al.  Mental Health and Sleep in Permanent Atrial Fibrillation Patients From the General Population , 2011, Clinical cardiology.

[11]  S. Kasper,et al.  A comparison of the Major Depression Inventory (MDI) and the Beck Depression Inventory (BDI) in severely depressed patients , 2011, International journal of psychiatry in clinical practice.

[12]  Rafael A. Peinado,et al.  Diferencias en la calidad de vida según el tipo de fibrilación auricular , 2010 .

[13]  E. Smolis-Bąk,et al.  Quality of life and depression in patients with different patterns of atrial fibrillation. , 2010, Kardiologia polska.

[14]  C. Doyle,et al.  Opening the door to older consumers: Pandora's box or the way ahead? , 2010, International Psychogeriatrics.

[15]  J. Maessen,et al.  A Prospective Randomized Multicenter Comparison on Health‐Related Quality of Life: The Value of Add‐On Arrhythmia Surgery in Patients with Paroxysmal, Permanent or Persistent Atrial Fibrillation Undergoing Valvular and/or Coronary Bypass Surgery , 2010, Journal of cardiovascular electrophysiology.

[16]  Pamela J. McCabe Psychological Distress in Patients Diagnosed With Atrial Fibrillation: The State of the Science , 2010, The Journal of cardiovascular nursing.

[17]  N. Frasure-smith,et al.  Elevated Depression Symptoms Predict Long-Term Cardiovascular Mortality in Patients With Atrial Fibrillation and Heart Failure , 2009, Circulation.

[18]  Stephan Willems,et al.  Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  A. Skanes,et al.  Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale , 2009, Circulation. Arrhythmia and electrophysiology.

[20]  G. Breithardt,et al.  The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  C. Herrmann-Lingen,et al.  Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. , 2007, Journal of psychosomatic research.

[22]  G. Breithardt,et al.  Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[23]  E. Elm,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[24]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[25]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, Annals of Internal Medicine [serial online].

[26]  Erik von Elm,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[27]  G. Lip,et al.  Depression, anxiety, and quality of life in patients with atrial fibrillation. , 2007, Chest.

[28]  P. Cuijpers,et al.  Sensitivity and specificity of the Major Depression Inventory in outpatients , 2007, BMC psychiatry.

[29]  E. W. Schneeberger,et al.  Absence of correlation between symptoms and rhythm in "symptomatic" atrial fibrillation. , 2007, The Annals of thoracic surgery.

[30]  Robert A. Cribbie,et al.  Gender differences and quality of life in atrial fibrillation: the mediating role of depression. , 2006, Journal of psychosomatic research.

[31]  Robert A. Cribbie,et al.  Psychological Correlates of Quality of Life in Atrial Fibrillation , 2006, Quality of Life Research.

[32]  G. Lip,et al.  Quality of life in patients with atrial fibrillation: a systematic review. , 2006, The American journal of medicine.

[33]  G. Breithardt,et al.  Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial. , 2005, American heart journal.

[34]  D. Schwartzman,et al.  Understanding Atrial Symptom Reports: Objective versus Subjective Predictors , 2005, Pacing and clinical electrophysiology : PACE.

[35]  A. Rozanski Integrating psychologic approaches into the behavioral management of cardiac patients. , 2005, Psychosomatic medicine.

[36]  P. Bech,et al.  Prevalence of major depression and stress indicators in the Danish general population , 2004, Acta psychiatrica Scandinavica.

[37]  P. Dorian,et al.  Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation. , 2003, Cardiac electrophysiology review.

[38]  P. Bech,et al.  The internal and external validity of the Major Depression Inventory in measuring severity of depressive states , 2003, Psychological Medicine.

[39]  P Bech,et al.  The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. , 2001, Journal of affective disorders.

[40]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[41]  M. Ezekowitz,et al.  Exercise Tolerance and Quality of Life in Elderly Patients with Chronic Atrial Fibrillation , 2001, Journal of cardiovascular pharmacology and therapeutics.

[42]  I. V. Van Gelder,et al.  Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system. , 2001, European heart journal.

[43]  J. Camm,et al.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. , 2000, Journal of the American College of Cardiology.

[44]  J. Blumenthal,et al.  Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. , 1999, Circulation.

[45]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[46]  R. Bubien,et al.  Quality of life in patients with atrial fibrillation. , 1996, Cardiology clinics.

[47]  S. Greenland,et al.  Simulation study of confounder-selection strategies. , 1993, American journal of epidemiology.

[48]  Gerhard Hindricks,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[49]  X. Badia,et al.  Variation in quality of life with type of atrial fibrillation. , 2010, Revista espanola de cardiologia.

[50]  S. Willich,et al.  [Health-related quality of life of patients with atrial fibrillation managed by cardiologists: MOVE study]. , 2010, Deutsche medizinische Wochenschrift.

[51]  S. Pocock,et al.  [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]. , 2008, Revista espanola de salud publica.

[52]  G. Breithardt,et al.  Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial , 2007, Clinical drug investigation.